View More Recent Stories

Jun 25, 2025 07:07PM ROSEN, A LEADING LAW FIRM, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PEPG
Jun 24, 2025 07:01PM ROSEN, A LEADING LAW FIRM, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PEPG
Jun 24, 2025 04:00PM PEPG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that PepGen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jun 23, 2025 06:25PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PEPG
Jun 23, 2025 11:03AM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen
Jun 22, 2025 12:23PM ROSEN, A LONGSTANDING FIRM, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PEPG
Jun 22, 2025 09:18AM PEPG Investors Have the Opportunity to Lead the PepGen Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Jun 20, 2025 06:36PM ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PEPG
Jun 19, 2025 08:14PM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen
Jun 19, 2025 06:31PM ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PEPG
Jun 18, 2025 06:25PM ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PEPG
Jun 18, 2025 04:00PM PEPG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that PepGen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jun 17, 2025 04:42PM ROSEN, A LONGSTANDING FIRM, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PEPG
Jun 17, 2025 11:26AM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen
Jun 15, 2025 03:07PM ROSEN, A LEADING LAW FIRM, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PEPG
Jun 14, 2025 02:41PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PEPG
Jun 13, 2025 02:37PM ROSEN, A LEADING LAW FIRM, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PEPG
Jun 12, 2025 04:00PM PEPG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that PepGen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jun 11, 2025 01:51PM Faruqi & Faruqi Reminds PepGen Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025 - PEPG
May 30, 2025 06:40AM PepGen Inc. (PEPG) PT Lowered to $8 at H.C. Wainwright
May 20, 2025 07:00AM PepGen (PEPG) Appoints Kasra Kasraian, PhD, as Chief Technology Officer
May 9, 2025 07:02AM PepGen Inc. (PEPG) PT Lowered to $14 at H.C. Wainwright
May 8, 2025 05:25PM PepGen Inc. (PEPG) Misses Q1 EPS by 20c
Mar 31, 2025 04:06PM PepGen (PEPG) Appoints Lisa Wyman and Mitchell H. Finer to its Board
Mar 4, 2025 08:00AM PepGen (PEPG) Announces Update to Phase 2 CONNECT2-EDO51 Study
Feb 24, 2025 05:20PM PepGen Inc. (PEPG) Tops Q4 EPS by 13c
Feb 24, 2025 12:29PM PepGen Inc. (PEPG) PT Lowered to $14 at Stifel
Feb 24, 2025 07:04AM PepGen (PEPG) Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1
Jan 31, 2025 06:41AM PepGen Inc. (PEPG) PT Lowered to $16 at H.C. Wainwright
Jan 29, 2025 04:09PM PepGen (PEPG) Provides CONNECT Program Updates
Dec 16, 2024 12:10PM BofA Securities Downgrades PepGen Inc. (PEPG) to Underperform
Dec 16, 2024 08:00AM PepGen (PEPG) Announces Clinical Hold in the U.S. on IND Application to Initiate CONNECT2-EDO51 Phase 2 Study of PGN-EDO51 for Duchenne Muscular Dystrophy
Nov 18, 2024 05:15AM PepGen Inc. (PEPG) PT Lowered to $6 at BofA Securities
Nov 7, 2024 05:35PM PepGen Inc. (PEPG) Tops Q3 EPS by 21c
Sep 19, 2024 04:30PM PepGen (PEPG) Announces Resignation of Christopher Ashton from Board
Aug 8, 2024 08:12AM PepGen Inc. (PEPG) Misses Q2 EPS by 15c
Jul 30, 2024 04:02PM PepGen (PEPG) Reports Positive Data from Low-Dose Cohort of PGN-EDO51
Jun 28, 2024 04:08PM PepGen (PEPG) Files $250M Mixed Shelf
Jun 11, 2024 07:01AM PepGen (PEPG) Appoints Michelle Mellion as Chief Medical Officer
View More Recent Stories